Sotera Health Announces Second-Quarter 2023 Earnings Release Date
CLEVELAND, July 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2023 before the market opens on Thursday, August 3, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
To participate in the live call, please dial 1-877-270-2148 if dialing-in from the United States, or 1-412-902-6510 if dialing-in from other locations. For direct connection to the conference call, participants are strongly encouraged to register in advance at this . A live webcast of the conference call and accompanying materials may also be accessed via the Investor Relations section of the Company’s website at . A replay of the webcast will be available later in the day on August 3rd.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at . For developments related to Ethylene Oxide, updates can be found at .
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
| Contacts | |
| Jason Peterson | |
| Vice President & Treasurer, Sotera Health | |
| Kristin Gibbs | |
| Chief Marketing Officer, Sotera Health | |
Source: Sotera Health Company
